Skip to main content
. 2021 Jan 2;2021:9526701. doi: 10.1155/2021/9526701

Table 2.

Glucose-lowering medication in patients of COVID-19 with T2DM.

Glucose-lowering medication Case (%)
Metformin 12 (16.90%)
Insulin 7 (9.86%)
Acarbose 6 (8.45%)
SGLT2-I 2 (2.82%)
Pioglitazone 1 (1.41%)

SGLT2: sodium-dependent glucose transporters 2 inhibitors.